My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Apple Q2 Preview: A New CEO, AI Doubts — Ever...
Alphabet's 'Phenomenal' Quarter Powers Bigges...
Royal Caribbean Delivers Profit Surprise, Sto...
AI Memory Crunch Sends Storage Stocks Higher...
Caterpillar's Profit Engine Fires, But Tariff...
Microsoft Stock Falls On Q3 Earnings: Analyst...
Homeowners Insurance Premiums Jump 64% Since...
SoftBank Eyes 2026 IPO For New AI-Robotics Ve...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    ASTELLAS PHARMA UNSP ADR EACH REPR 1 ORD (OTCi: ALPMY)

    Overview
    current price
    $14.30
    $14.30
    change
    0.10 | 0.70%
    0.10 | 0.70%
    Yesterday's Close
    14.20
    open
    14.21
    volume
    0.22 M
    30d. avg volume.
    0.14 M
    1 day
    14.05 - 14.42
    52 weeks
    8.97 - 17.35
    p/e
    13.65
    beta
    0.2080
    market cap
    25.70 B
    dividend yield
    0.00%
    Industry
    -
    ALPMY by TradingView
    News and Commentary
    From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sach Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments.This signif...
    IPO Market Continues Record Pace with 18 Listings Last Week The initial public offering (IPO) market continued at its red hot pace last week with 18 traditional IPOs listing on U.S. markets, marking the fourth week this year with at least...
    StockTwits
    StockTwits
    Most Shared
    IBM AI Success Faces Macro Headwinds: Analyst Cuts Price Target
    SpaceX IPO Would Test A Brutal Truth: Most IPOs Since 2021 Destroyed Value
    US Economy Stays Resilient, But 'Significant Risks' Are Building Fast, Jamie Dimon Warns
    Most Popular
    AMD Says Space Needs Smarter Chips Now And It's Ready To Deliver
    SpaceX IPO Would Test A Brutal Truth: Most IPOs Since 2021 Destroyed Value
    Watch Out Tesla ― NIO March Deliveries Surged 136%
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Coronavirus Impact
    Tesla
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?